This is a Validated Antibody Database (VAD) review about human BRF1, based on 3 published articles (read how Labome selects the articles), using BRF1 antibody in all methods. It is aimed to help Labome visitors find the most suited BRF1 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
BRF1 synonym: BRF; BRF-1; CFDS; GTF3B; HEL-S-76p; TAF3B2; TAF3C; TAFIII90; TF3B90; TFIIIB90; hBRF; transcription factor IIIB 90 kDa subunit; B - related factor 1; BRF1 homolog, subunit of RNA polymerase III transcription initiation factor IIIB; BRF1, RNA polymerase III transcription initiation factor 90 kDa subunit; TATA box binding protein (TBP)-associated factor 3C; TATA box binding protein (TBP)-associated factor, RNA polymerase III, GTF3B subunit 2; TBP - associated factor, RNA polymerase III, 90kD; epididymis secretory sperm binding protein Li 76p; general transcription factor IIIB, 90kD subunit
Bethyl
rabbit polyclonal |
| Bethyl BRF1 antibody (Bethyl Laboratories, A301-228A) was used in western blot on human samples (fig 2). BMC Cancer (2015) ncbi |
rabbit polyclonal |
| Bethyl BRF1 antibody (Bethyl Laboratories, A301-228A) was used in western blot on human samples . Mol Cell Biol (2015) ncbi |
Santa Cruz Biotechnology
mouse monoclonal (BRF1G2A8) |
| In order to elucidate how cytoskeletal filamin A suppresses cell proliferation, Santa Cruz Biotechnology BRF1 antibody (Cruz Biotech, SC-81405) was used in immunohistochemistry on human samples (fig 6a) and in western blot on human samples (fig 6e). J Biol Chem (2016) ncbi |
Articles Reviewed
- Wang J, Zhao S, Wei Y, Zhou Y, Shore P, Deng W. Cytoskeletal Filamin A Differentially Modulates RNA Polymerase III Gene Transcription in Transformed Cell Lines. J Biol Chem. 2016;291:25239-25246 pubmed
contribute
- If you are aware of any publication with knockout studies validating a monoclonal or recombinant antibody, either purchased from a supplier or developed by the author(s), please notify us through feedback.
questions and comments